Michael Handelman, age 52, currently serves as the Chief Financial Officer of Oxis International. Before joining Oxis, he served as Chief Financial Officer and Chief Operating Officer of TechnoConcepts, Inc., a developing technology and manufacturing company. Prior to that, he was Chief Financial Officer of Interglobal Waste Management, Inc., a start-up manufacturing company. Mr. Handelman has also been Chief Financial Officer of the Los Angeles Kings, a National Hockey League franchise. He is a certified public accountant and holds a degree in accounting from the City University of New York.
About Genesis Biopharma, Inc.
Genesis Biopharma, Inc. is a development-stage biotechnology company engaged primarily in the development of targeted cancer therapies. For more information on the company, visit www.genesis-biopharma.com.
The foregoing press announcement contains forward-looking statements that can be identified by such terminology as "expect," "potential," "suggests," "bodes," "may," "should," "could" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's ex
|SOURCE Genesis Biopharma, Inc.|
Copyright©2010 PR Newswire.
All rights reserved